Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCS_A
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Date: 2021-01-11 Method: X-RAY DIFFRACTION Resolution: 1.93 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LCT_A
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Lu, J. , Young, H.S.
Date: 2021-01-13 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 7LDL_A , 7LDL_B
Crystal structure of main protease of sars-cov-2 complexed with inhibitor Deposition Author(s): Arutyunova, E. , Chen, P. , Khan, M.B. , Lemieux, M.J. , Lu, J. , Young, H.S.
Date: 2023-01-11 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 8FTC_A
Crystal structure of mers-cov nsp5 in complex with pf-07817883 Deposition Author(s): Arutyunova, E. , Chen, P. , Lemieux, M.J.
Date: 2024-05-05 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Middle East Respiratory Syndrome-Related Coronavirus Sequences Data: 9BOO_A
Crystal structure of main protease of sars-cov-2 complexed with inhibitor Deposition Author(s): Arutyunova, E. , Chen, P. , Lemieux, M.J.
Date: 2024-05-07 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9BPF_A , 9BPF_B